180 related articles for article (PubMed ID: 26586132)
1. Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity.
Tenreiro S; Rosado-Ramos R; Gerhardt E; Favretto F; Magalhães F; Popova B; Becker S; Zweckstetter M; Braus GH; Outeiro TF
Hum Mol Genet; 2016 Jan; 25(2):275-90. PubMed ID: 26586132
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast.
Brás IC; Tenreiro S; Silva AM; Outeiro TF
FEMS Yeast Res; 2018 Dec; 18(8):. PubMed ID: 30277516
[TBL] [Abstract][Full Text] [Related]
3. Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays.
Lek S; Vargas-Medrano J; Villanueva E; Marcus B; Godfrey W; Perez RG
J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829427
[TBL] [Abstract][Full Text] [Related]
4. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.
Lázaro DF; Dias MC; Carija A; Navarro S; Madaleno CS; Tenreiro S; Ventura S; Outeiro TF
Acta Neuropathol Commun; 2016 Dec; 4(1):128. PubMed ID: 27938414
[TBL] [Abstract][Full Text] [Related]
5. Toxic effects of human and rodent variants of alpha-synuclein in vivo.
Landeck N; Buck K; Kirik D
Eur J Neurosci; 2017 Feb; 45(4):536-547. PubMed ID: 27893183
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.
Tenreiro S; Reimão-Pinto MM; Antas P; Rino J; Wawrzycka D; Macedo D; Rosado-Ramos R; Amen T; Waiss M; Magalhães F; Gomes A; Santos CN; Kaganovich D; Outeiro TF
PLoS Genet; 2014 May; 10(5):e1004302. PubMed ID: 24810576
[TBL] [Abstract][Full Text] [Related]
7. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.
Lázaro DF; Rodrigues EF; Langohr R; Shahpasandzadeh H; Ribeiro T; Guerreiro P; Gerhardt E; Kröhnert K; Klucken J; Pereira MD; Popova B; Kruse N; Mollenhauer B; Rizzoli SO; Braus GH; Danzer KM; Outeiro TF
PLoS Genet; 2014 Nov; 10(11):e1004741. PubMed ID: 25393002
[TBL] [Abstract][Full Text] [Related]
8. Age-Related Changes of the Synucleins Profile in the Mouse Retina.
Dias SB; de Lemos L; Sousa L; Bitoque DB; Silva GA; Seabra MC; Tenreiro S
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671565
[TBL] [Abstract][Full Text] [Related]
9. Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease.
Gonçalves SA; Outeiro TF
Small GTPases; 2017 Apr; 8(2):78-84. PubMed ID: 27314512
[TBL] [Abstract][Full Text] [Related]
10. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression.
Fan Y; Limprasert P; Murray IV; Smith AC; Lee VM; Trojanowski JQ; Sopher BL; La Spada AR
Hum Mol Genet; 2006 Oct; 15(20):3002-11. PubMed ID: 16959793
[TBL] [Abstract][Full Text] [Related]
11. Membrane binding, internalization, and sorting of alpha-synuclein in the cell.
Masaracchia C; Hnida M; Gerhardt E; Lopes da Fonseca T; Villar-Pique A; Branco T; Stahlberg MA; Dean C; Fernández CO; Milosevic I; Outeiro TF
Acta Neuropathol Commun; 2018 Aug; 6(1):79. PubMed ID: 30107856
[TBL] [Abstract][Full Text] [Related]
12. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
Wales P; Pinho R; Lázaro DF; Outeiro TF
J Parkinsons Dis; 2013; 3(4):415-59. PubMed ID: 24270242
[TBL] [Abstract][Full Text] [Related]
13. Counter-regulation of alpha- and beta-synuclein expression at the transcriptional level.
Wright JA; McHugh PC; Pan S; Cunningham A; Brown DR
Mol Cell Neurosci; 2013 Nov; 57():33-41. PubMed ID: 24080388
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.
Popova B; Kleinknecht A; Braus GH
Biomolecules; 2015 Apr; 5(2):617-34. PubMed ID: 25915624
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity.
Ferreira DG; Batalha VL; Vicente Miranda H; Coelho JE; Gomes R; Gonçalves FQ; Real JI; Rino J; Albino-Teixeira A; Cunha RA; Outeiro TF; Lopes LV
Cereb Cortex; 2017 Jan; 27(1):718-730. PubMed ID: 26534909
[TBL] [Abstract][Full Text] [Related]
16. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.
Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M
J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040
[TBL] [Abstract][Full Text] [Related]
17. E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.
Íñigo-Marco I; Valencia M; Larrea L; Bugallo R; Martínez-Goikoetxea M; Zuriguel I; Arrasate M
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8274-E8283. PubMed ID: 28900007
[TBL] [Abstract][Full Text] [Related]
18. Residual structure, backbone dynamics, and interactions within the synuclein family.
Sung YH; Eliezer D
J Mol Biol; 2007 Sep; 372(3):689-707. PubMed ID: 17681534
[TBL] [Abstract][Full Text] [Related]
19. Modulation of alpha-synuclein toxicity in yeast using a novel microfluidic-based gradient generator.
Fernandes JT; Tenreiro S; Gameiro A; Chu V; Outeiro TF; Conde JP
Lab Chip; 2014 Oct; 14(20):3949-57. PubMed ID: 25167219
[TBL] [Abstract][Full Text] [Related]
20. shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity.
Gonçalves SA; Macedo D; Raquel H; Simões PD; Giorgini F; Ramalho JS; Barral DC; Ferreira Moita L; Outeiro TF
PLoS Genet; 2016 Apr; 12(4):e1005995. PubMed ID: 27123591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
